Dexr mark
Dexr x Spreds

Round two on Spreds

In 2025, our first crowdfunding round was a success and brought in €176K from people who believed in Dexr. Now we're taking the next step.

2025
Round one: €176K
Thank you to everyone who joined us!
Backed by
Imec.Istart FundPMVTotal of €529K in VLAIO grants
Now
Round two
The last round with the 45% tax shelter. Open until 14 December 2026.
2027
Series A
A larger round to grow across Europe.

What is Spreds?

A Belgian crowdfunding platform where you can invest in startups and become a shareholder, from €500. Spreds screens every startup, handles the paperwork and holds the shares on behalf of all investors.

Why we built Dexr

We learn by doing, not by slides

We still learn practical skills from slides and manuals, far from the real work. So the first real practice happens on the job, where a mistake costs money, or worse.

Electrical safety: measuring before you touchThe Dexr editor: describe the training, and AI builds the steps for you to checkLockout and tagout, step by stepHealthcare: a sterile procedure, practiced until it feels naturalWorking at height, with both feet on the groundA test on site: what people can do, not what they rememberThe Dexr editor: turn a photo into a 3D model in minutes

Electrical safety: measuring before you touch

Take Tom, an electrician. Here is how his training goes with Dexr.

Step 1
Built in minutes

A trainer uses our platform to create a 3D training procedure in minutes.

Step 2
On any device

Tom practices in VR, then again on his laptop and on his phone.

Step 3
Measured every time

A re-test shows he is ready.

48% → 91%
Step 4
Ready on site

His first real cabinet is not his first try.

Step 5
Stays sharp

A few months later, a short re-test checks his skills. If something has slipped, he practices that part again.

Where we stand

Dexr at a glance

Platform live
Mid 2024

founded in December 2022

Beta
700+

organizations tried Dexr

Team
7 FTE

three founders and a core team

Pipeline
±40

discovery meetings a month

Target revenue
€400K

this year, and we’re on track

Clients
Unilin, Actemium, ILVO, University of the Free State

and many schools and training centers

Backed by
Imec.Istart Fund, PMV, €529K in VLAIO grants

from two approved VLAIO development projects

For Belgian investors

Get 45% back through your taxes

Investment€1,000
Spreds fee3% in the private phase, 5% in the public phase€30 to €50
Tax back (45%)-€450
Net cost€580 to €600
You pay taxes in BelgiumAnd you invest in your own name, not through a company.
You pay enough income taxFor €1,000 invested, you need at least €450 in income tax that year.
You keep your shares for 4 yearsIf you sell earlier, you lose part of the tax benefit.
Up to €100,000 a yearPer person, for all your tax shelter investments together. Dexr directors can’t use it.

This comes from the Belgian Tax Shelter for startups, and this is the last year we can offer it. This is not financial or tax advice.

An illustration

What could €1,000 be worth?

Say you invest €1,000 in this round. With 45% back through your taxes, it costs you about €600. Here is what you would get back at different exit values, after about 5 to 8 years.

Dexr’s value at exitYou receiveCompared to your €600
-100% (Dexr fails)€0-€600
-50%€500-€100
-40% (break-even)€600€0
0% (same value as today)€1,000+€400
+100%€1,868+€1,268
+200%€2,668+€2,068
+658%Our plan: €8M yearly revenue, valued at 4x€6,331+€5,731
+1,037%Our plan: €12M yearly revenue, valued at 4x€9,361+€8,761

An illustration only, not a promise. Amounts are after the Spreds success fee. The highlighted rows are based on our own targets, valued at 4x yearly revenue, without later funding rounds.

Campaign open until 14 December 2026

Come along for the ride

Visit the Spreds campaign pagehttps://www.spreds.com/en/compartments/10940-dexr

Investing in a startup comes with risks, and you could lose part or all of your money. Read the Key Investment Information Sheet and the risk factors on Spreds before you invest.

Questions? Just send a message to leonard@dexr.eu

Dexr